Article
Confirmation of a second locus for CMT2 and evidence for additional genetic heterogeneity.
Neurogenetics - 1 Sept 1997
Pericak-Vance M A, Speer M C, Lennon F, West S G, Menold M M, Stajich J M, Wolpert C M, Slotterbeck B D, Saito M, Tim R W, Rozear M P, Middleton L T, Tsuji S, Vance J M
Abstract excerpt
The Charcot-Marie-Tooth (CMT) neuropathies are a group of disorders exhibiting neurophysical, pathological and genetic heterogeneity. CMT2 is a diagnostic subtype of this group of disorders characterized by variable expression and age-of-onset and normal or slightly diminished nerve conduction ve...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
